[Meprotixol (N 7020). Clinical experiences in rheumatic diseases].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D013892:Thioxanthenes / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010919:Placebos; D013892:Thioxanthenes; D010653:Phenylbutazone
Meprotixol (n 7020). kliniske erfaringer ved reumatiske lidelser.